First patient treated in phase 2 obesity trial of GLY-200 polymer
Glyscend Therapeutics has initiated a Phase 2 clinical trial of its lead candidate, GLY-200, as a novel oral treatment for obesity....
top of page
Browse by category
Search
Therapeutic polymer could provide alternative to gastric bypass
An orally administered therapeutic polymer, GLY-200, designed to bind to and enhance the barrier function of mucus in the...
Browse by tag
bottom of page